Skip to main content

Advertisement

Log in

Navigating the road ahead: addressing challenges for use of metabolomics in epidemiology studies

  • Opinion
  • Published:
Metabolomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Berry, D. (2012). Multiplicities in cancer research: Ubiquitous and necessary evils. Journal of the National Cancer Institute, 104, 1124–1132.

    Article  PubMed  Google Scholar 

  • Broadhurst, D. I., & Kell, D. B. (2006). Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics, 2, 171–196.

    Article  CAS  Google Scholar 

  • Diamandis, E. P. (2010). Cancer biomarkers: Can we turn recent failures into success? Journal of the National Cancer Institute, 102, 1462–1467.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ernester, V. L. (1994). Nested case-control studies. Preventive Medicine, 23, 587–590.

    Article  Google Scholar 

  • Qian, G. S., Ross, R. K., Yu, M. C., Yuan, J. M., Gao, Y. T., Henderson, B. E., et al. (1994). A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People’s Republic of China. Cancer Epidemiology, Biomarkers and Prevention, 3, 3–10.

    CAS  PubMed  Google Scholar 

  • Salek, R. M., Steinbeck, C., Goodacre, R., Viant, M. R., & Dunn, W. B. (2013). The role of reporting standards for metabolite annotation and identification in metabolomic studies. GigaScience, 2, 13.

    Article  PubMed  PubMed Central  Google Scholar 

  • Sampson, J. N., Boca, S. M., Shu, X. O., Stolzenberg-Soloman, R. Z., Matthews, C. E., Hsing, A. W., et al. (2013). Metabolomics in epidemiology: Sources of variability in metabolite measurements and implications. Cancer Epidemiology, Biomarkers and Prevention, 22, 631–640.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schairer, C., Lubin, J., Troisi, R., Sturgeon, S., Brinton, L., & Hoover, R. (2000). Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. Journal of the American Medical Association, 283, 485–491.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Krista A. Zanetti.

Additional information

Majda Haznadar, Padma Maruvada, Eliza Mette, John Milner, Steven C. Moore, Holly L. Nicastro, Joshua N. Sampson, L. Joseph Su, and Mukesh Verma have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haznadar, M., Maruvada, P., Mette, E. et al. Navigating the road ahead: addressing challenges for use of metabolomics in epidemiology studies. Metabolomics 10, 176–178 (2014). https://doi.org/10.1007/s11306-014-0636-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11306-014-0636-z

Navigation